Reata Pharmaceuticals Inc logo

Reata Pharmaceuticals Inc

$ 22.97 +0.85 (+3.84%) 10:08 PM EST
P/E:
At Loss
P/B:
12.22
Market Cap:
$ 838.33M
Enterprise V:
$ 468.35M
Volume:
758.42K
Avg Vol (2M):
988.43K
Also Trade In:
Volume:
758.42K
Market Cap $:
838.33M
PE Ratio:
At Loss
Avg Vol (2-Month):
988.43K
Enterprise Value $:
468.35M
PB Ratio:
12.22
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others.
Name Current Vs Industry Vs History
Cash-To-Debt 3.38
Equity-to-Asset 0.11
Debt-to-Equity 2.08
Debt-to-EBITDA -0.56
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.73
Distress
Grey
Safe
Beneish M-Score -1.13
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 30.12
9-Day RSI 38.02
14-Day RSI 41.96
6-1 Month Momentum % -32.23
12-1 Month Momentum % -77.57

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.6
Quick Ratio 10.6
Cash Ratio 10.39

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7

Financials (Next Earnings Date:2022-11-08 Est.)

RETA's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RETA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 10
EPS (TTM) ($) -8.37
Beta 0.54
Volatility % 79.2
14-Day RSI 41.96
14-Day ATR ($) 2.206123
20-Day SMA ($) 25.5825
12-1 Month Momentum % -77.57
52-Week Range ($) 18.47 - 114.8
Shares Outstanding (Mil) 36.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Reata Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Reata Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.